Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) | PAR-19-353 | NCI | This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the… More | ||
| Notice of Availability of Administrative Supplements for Geospatial, Multilevel, and Contextual Approaches in Cancer Control and Population Sciences | NOT-CA-19-029 | NCI | N/A | Notice Availability Administrative Supplements Geospatial, Multilevel, Contextual Approaches Cancer Control Population Sciences Notice Number: NOT-CA-19-029 Key Dates Release Date: March 12, 2019… More | |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | RFA-CA-21-014 | NCI | The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research… More | ||
| Notice of Availability of Administrative Supplements for Integrative Data Analysis to extend Research in Cancer Control and Population Sciences (Admin Supp Clinical Trial - Optional) | NOT-CA-18-087 | NCI | N/A | Notice Availability Administrative Supplements Integrative Data Analysis Extend Research Cancer Control Population Sciences Admin Supp Clinical Trial - Optional) Notice Number: NOT-CA-18-087 Key… More | |
| Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) | PAR-19-361 | NCI | This Funding Opportunity Announcement (FOA) invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are: 1) to improve… More | ||
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | PAR-19-113 | NCI | This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative,… More | ||
| NCI Participation in PAR-18-694, Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 - Clinical Trial Optional) | NOT-CA-18-066 | NCI | N/A | NCI Participation PAR-18-694, Interdisciplinary Research Teams Investigate Reciprocal Basic Behavioral Social Linkages Between Sleep Stress R24 - Clinical Trial Optional) Notice Number: NOT-CA-18-… More | |
| Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) | PAR-19-309 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to provide support for the development of innovative interventions that improve cancer-related health behaviors across diverse racial/… More | ||
| Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) | PAR-19-354 | NCI | This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the… More | ||
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | RFA-CA-21-036 | NCI | This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage… More |